• 2024
  Brault A, Pontais I, Enouf V, Debeuret C, Bloch E, Paireau J, Rameix-Welti MA, White M, Baudemont G, Lina B, Parent du Châtelet I, Casalegno JS, Vaux S, Cauchemez S, Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study., Lancet Child Adolesc Health 2024 Oct; 8(10): 721-729.
• 2023
  Andronico A, Menudier L, Salje H, Vincent M, Paireau J, de Valk H, Gallian P, Pastorino B, Brady O, de Lamballerie X, Lazarus C, Paty MC, Vilain P, Noel H, Cauchemez S, Comparing the Performance of Three Models Incorporating Weather Data to Forecast Dengue Epidemics in Reunion Island, 2018-2019., J Infect Dis 2023 Nov; (): .
• 2023
  Tan-Lhernould L, Tamandjou C, Deschamps G, Platon J, Sommen C, Chereau F, Parent du Châtelet I, Cauchemez S, Vaux S, Paireau J, Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study., BMC Med 2023 Nov; 21(1): 426.
• 2023
  Franconeri L, Antona D, Cauchemez S, Lévy-Bruhl D, Paireau J, Two-dose measles vaccine effectiveness remains high over time: A French observational study, 2017-2019., Vaccine 2023 Aug; (): .
• 2023
  Brault A, Tran-Kiem C, Couteaux C, Olié V, Paireau J, Yazdanpanah Y, Ghosn J, Martin-Blondel G, Bosetti P, Cauchemez S, , Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna., Lancet Reg Health West Pac 2023 Jan; 30(): 100634.
• 2022
  Ten Bosch Q, Andrianaivoarimanana V, Ramasindrazana B, Mikaty G, Rakotonanahary RJ, Nikolay B, Rahajandraibe S, Feher M, Grassin Q, Paireau J, Rahelinirina S, Randremanana R, Rakotoarimanana F, Melocco M, Rasolofo V, Pizarro-Cerda J, Le Guern AS, Bertherat E, Ratsitorahina M, Spiegel A, Baril L, Rajerison M, Cauchemez S, , Analytical framework to evaluate and optimize the use of imperfect diagnostics to inform outbreak response: Application to the 2017 plague epidemic in Madagascar., PLoS Biol 2022 Aug; 20(8): e3001736.
• 2022
  Paireau J, Andronico A, Hozé N, Layan M, Crépey P, Roumagnac A, Lavielle M, Boëlle PY, Cauchemez S, , An ensemble model based on early predictors to forecast COVID-19 health care demand in France., Proc Natl Acad Sci U S A 2022 May; 119(18): e2103302119.
• 2022
  Grant R, Charmet T, Schaeffer L, Galmiche S, Madec Y, Von Platen C, Chény O, Omar F, David C, Rogoff A, Paireau J, Cauchemez S, Carrat F, Septfons A, Levy-Bruhl D, Mailles A, Fontanet A, , Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France., Lancet Reg Health Eur 2022 Feb; 13(): 100278.
• 2022
  Paireau J, Mailles A, Eisenhauer C, de Laval F, Delon F, Bosetti P, Salje H, Pontiès V, Cauchemez S, , Early chains of transmission of COVID-19 in France, January to March 2020., Euro Surveill 2022 02; 27(6): .
• 2022
  Bosetti P, Tran Kiem C, Andronico A, Paireau J, Levy-Bruhl D, Alter L, Fontanet A, Cauchemez S, , Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22., Euro Surveill 2022 01; 27(1): .
• 2021
  Tran Kiem C, Bosetti P, Paireau J, Crépey P, Salje H, Lefrancq N, Fontanet A, Benamouzig D, Boëlle PY, Desenclos JC, Opatowski L, Cauchemez S, , SARS-CoV-2 transmission across age groups in France and implications for control., Nat Commun 2021 11; 12(1): 6895.
• 2021
  Galmiche S, Charmet T, Schaeffer L, Paireau J, Grant R, Chény O, Von Platen C, Maurizot A, Blanc C, Dinis A, Martin S, Omar F, David C, Septfons A, Cauchemez S, Carrat F, Mailles A, Levy-Bruhl D, Fontanet A, , Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study., Lancet Reg Health Eur 2021 Aug; 7(): 100148.
• 2021
  Tran Kiem C, Andronico A, Bosetti P, Paireau J, Alter L, Boëlle PY, Fontanet A, Lévy-Bruhl D, Cauchemez S, , Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021., Euro Surveill 2021 07; 26(26): .
• 2021
  Lefrancq N, Paireau J, Hozé N, Courtejoie N, Yazdanpanah Y, Bouadma L, Boëlle PY, Chereau F, Salje H, Cauchemez S, , Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis., Lancet Reg Health Eur 2021 Jun; 5(): 100087.
• 2021
  Hozé N, Paireau J, Lapidus N, Tran Kiem C, Salje H, Severi G, Touvier M, Zins M, de Lamballerie X, Lévy-Bruhl D, Carrat F, Cauchemez S, , Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study., Lancet Public Health 2021 Apr; (): .
• 2021
  Andronico A, Tran Kiem C, Paireau J, Succo T, Bosetti P, Lefrancq N, Nacher M, Djossou F, Sanna A, Flamand C, Salje H, Rousseau C, Cauchemez S, , Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana., Nat Commun 2021 03; 12(1): 1634.
• 2021
  O'Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H, , Age-specific mortality and immunity patterns of SARS-CoV-2., Nature 2021 02; 590(7844): 140-145.
• 2020
  Cauchemez S, Kiem CT, Paireau J, Rolland P, Fontanet A, , Lockdown impact on COVID-19 epidemics in regions across metropolitan France., Lancet 2020 10; 396(10257): 1068-1069.